ClinicalTrials.gg
Drug

Edaravone clinical trials

Also written MCI-186, Radicut, MT-1186 and Radicava.

studies test it
38
open now
5
in phase 3
6
first study started
2001

How each study uses Edaravone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Edaravone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
5 May 2017 · RADICAVA · NDA 209176 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Edaravone
25
Edaravone Injection
3

Brand

Radicut
8
Radicava
3

Development codes

MCI-186
9
MT-1186
8

In one entry with another drug

Given together, or one or the other

Edaravone Dexborneol
8

Studies by the year they started

38 studies that test it; most in 2021 (7)

Studies that test Edaravone, by start year
YearStudies
20011
20042
20062
20071
20092
20111
20131
20163
20171
20184
20195
20202
20217
20222
20231
20241
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
14
Phase 2
9
Phase 3
6
Phase 4
7
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 21 · Other 17

Shionogi (18) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (2) · Beijing Suncadia Pharmaceuticals Co., Ltd (1) · Shanghai Auzone Biological Technology Co., Ltd. (1) · Hui-Sheng Chen (1) · Nanjing Yoko Biomedical Co., Ltd. (1) · Kumamoto University (1) · Combination Therapy for Acute Ischemic Stroke Study Group (1)

Often tested with

Tested in the same studies.

Dexborneol (8) · HRS-8829 (1) · Taurine (1) · Nerve Growth Factor (1) · Scopolamine (1) · Atropine (1) · Dexmedetomidine (1) · Urinastatin (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Edaravone.

Studies

Open first, then newest update. How each study uses Edaravone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 38

See all 38 studies that test Edaravone →

Given beside what is tested · 2 — Edaravone is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with Edaravone

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call Edaravone · ClinicalTrials.gg INT006749

  • MeSH (NLM) D000077553EdaravoneConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) S798V6YJRPEDARAVONEConfirmed FDA, NLM, Wikidata
  • RxNorm 1921877Confirmed FDA, Wikidata
  • Wikidata Q335099edaravoneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C74323EdaravoneConfirmed FDA, Wikidata
  • DrugBank DB12243One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.